Chantix top searched brand: survey

Share this article:
Pfizer's smoking cessation treatment Chantix was the top searched prescription brand in February, generating more than 500,000 search queries, according to internet measurement firm comScore. 
Shire's Adderall for ADHD and Pfizer's erectile dysfunction treatment Viagra came in a close second and third on the list, respectively.

Five of the 15 most frequently searched prescription brands were depression treatments. Those treatments included Lilly's Cymbalta and Prozac, Wyeth's Effexor, Forest's Lexapro and GlaxoSmithKline's Paxil.

Most Commonly Searched Prescription Brands
February 2008 Total US – Home/Work/University Locations

Brand Name Search queries (000)
Chantix 507
Adderall 469
Viagra 348
Ambien 334
Lexapro 274
Effexor 264
Cymbalta 235
Lyrica 233
Seroquel 198
Lipitor 181
Prozac 174
Cialis 120
Paxil 119
Crestor 119
Singulair 114
Source: comScore, Inc. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...